<VariationArchive RecordType="classified" VariationID="1305396" VariationName="NM_006186.4(NR4A2):c.326dup (p.Ser110fs)" VariationType="Duplication" Accession="VCV001305396" Version="3" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-12-25" DateCreated="2021-11-06" MostRecentSubmission="2023-03-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1295671" VariationID="1305396">
      <GeneList>
        <Gene Symbol="NR4A2" FullName="nuclear receptor subfamily 4 group A member 2" GeneID="4929" HGNC_ID="HGNC:7981" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q24.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="156324437" stop="156332721" display_start="156324437" display_stop="156332721" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="157180943" stop="157189286" display_start="157180943" display_stop="157189286" Strand="-" />
          </Location>
          <OMIM>601828</OMIM>
          <Haploinsufficiency last_evaluated="2022-09-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NR4A2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-09-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NR4A2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_006186.4(NR4A2):c.326dup (p.Ser110fs)</Name>
      <CanonicalSPDI>NC_000002.12:156329860:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2q24.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="156329860" stop="156329861" display_start="156329860" display_stop="156329861" variantLength="1" positionVCF="156329860" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="157186372" stop="157186373" display_start="157186372" display_stop="157186373" variantLength="1" positionVCF="157186372" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
      </Location>
      <ProteinChange>S110fs</ProteinChange>
      <ProteinChange>S47fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006186.3" sequenceAccession="NM_006186" sequenceVersion="3" change="c.326dupA">
            <Expression>NM_006186.3:c.326dupA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.157186373dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.157186373dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.156329861dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.156329861dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011821.1" sequenceAccession="NG_011821" sequenceVersion="1" change="g.7915dup">
            <Expression>NG_011821.1:g.7915dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006186.4" sequenceAccession="NM_006186" sequenceVersion="4" change="c.326dup" MANESelect="true">
            <Expression>NM_006186.4:c.326dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006177.1" sequenceAccession="NP_006177" sequenceVersion="1" change="p.Ser110fs">
            <Expression>NP_006177.1:p.Ser110fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_173173.3" sequenceAccession="NM_173173" sequenceVersion="3" change="c.137dup">
            <Expression>NM_173173.3:c.137dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_775265.1" sequenceAccession="NP_775265" sequenceVersion="1" change="p.Ser47fs">
            <Expression>NP_775265.1:p.Ser47fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="601828.0003" DB="OMIM" />
        <XRef Type="rs" ID="2105613409" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006186.4(NR4A2):c.326dup (p.Ser110fs) AND not provided" Accession="RCV001768603" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-04-26" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006186.4(NR4A2):c.326dup (p.Ser110fs) AND Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism" Accession="RCV002260708" Version="1">
        <ClassifiedConditionList TraitSetID="76351">
          <ClassifiedCondition DB="MedGen" ID="C5677001">Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-06-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-04-26" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2021-11-06" MostRecentSubmission="2023-03-04">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Uncertain significance</Description>
        <Citation Type="general">
          <ID Source="PubMed">31428396</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31922365</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="76351" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="62930" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism</ElementValue>
                <XRef ID="MONDO:0859257" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">IDLDP</ElementValue>
                <XRef Type="MIM" ID="619911" DB="OMIM" />
              </Symbol>
              <XRef ID="C5677001" DB="MedGen" />
              <XRef ID="MONDO:0859257" DB="MONDO" />
              <XRef Type="MIM" ID="619911" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4970008" SubmissionDate="2022-06-22" DateLastUpdated="2022-07-08" DateCreated="2022-07-08">
        <ClinVarSubmissionID localKey="601828.0003_INTELLECTUAL DEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND EARLY-ONSET DOPA-RESPONSIVE DYSTONIA-PARKINSONISM" title="NR4A2, 1-BP DUP, 326A_INTELLECTUAL DEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND EARLY-ONSET DOPA-RESPONSIVE DYSTONIA-PARKINSONISM" />
        <ClinVarAccession Accession="SCV002540591" DateUpdated="2022-07-08" DateCreated="2022-07-08" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-22">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 9-year-old boy with intellectual developmental disorder with language impairment and early-onset dopa-responsive dystonia-parkinsonism (IDLDP; 619911), Ramos et al. (2019) identified a de novo heterozygous 1-bp duplication (c.326dupA, ENST00000339562) in the NR4A2 gene, predicted to result in a frameshift and premature termination (Ser110ValfsTer2). The mutation was found by whole-exome sequencing and confirmed by Sanger sequencing. Functional studies of the variant and studies of patient cells were not performed, but it was predicted to result in a loss of function. At age 5 years, the patient developed seizures consistent with rolandic epilepsy.</Attribute>
              <Citation>
                <ID Source="PubMed">31428396</ID>
              </Citation>
              <XRef DB="OMIM" ID="619911" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Wirth et al. (2020) identified a de novo heterozygous c.326dupA mutation (c.326dupA, NM_006186.3) in exon 3 of the NR4A2 gene in a 37-year-old man (patient 1) with IDLDP. He had a history of mild global developmental delay with significant speech impairment since early childhood and developed dopa-responsive dystonia-parkinsonism at age 29 years. The mutation was found by whole-exome sequencing and confirmed by Sanger sequencing; functional studies of the variant and studies of patient cells were not performed.</Attribute>
              <Citation>
                <ID Source="PubMed">31922365</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NR4A2" />
          </GeneList>
          <Name>NR4A2, 1-BP DUP, 326A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 326A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="601828.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">INTELLECTUAL DEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND EARLY-ONSET DOPA-RESPONSIVE DYSTONIA-PARKINSONISM</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3887150" SubmissionDate="2021-10-31" DateLastUpdated="2023-03-04" DateCreated="2021-11-06">
        <ClinVarSubmissionID localKey="GDXSV:194259" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001992396" DateUpdated="2023-03-04" DateCreated="2021-11-06" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-04-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Comment>Frameshift variant predicted to result in nonsense mediated decay in a gene for which loss-of-function is not a known mechanism of disease; Not observed in large population cohorts (Lek et al., 2016); Has not been previously published as pathogenic or benign to our knowledge; Variants in candidate genes are classified as variants of uncertain significance in accordance with ACMG guidelines (Richards et al., 2015); This variant is associated with the following publications: (PMID: 31428396, 31922365)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NR4A2" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:2984216</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006186.3:c.326dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_65_20211031114953</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3887150" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4970008" TraitType="Disease" MappingType="Name" MappingValue="INTELLECTUAL DEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND EARLY-ONSET DOPA-RESPONSIVE DYSTONIA-PARKINSONISM" MappingRef="Preferred">
        <MedGen CUI="C5677001" Name="Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

